It's a great question and I have looked into it some. Everything I've read, and please correct me if I am wrong, says that lenacapavir is specific to the HIV capsid and will be a subcutaneous injection every 6 months alongside an additional antiviral regimen. The side effects aren't horrible but they aren't as limited as ours.

But to me, if I had to make a decision on treatments, I want leronlimab. You are not only preventing HIV from binding but think of all the other diseases you may be preventing and conditions you may be positively impacting. I see HIV as a catalyst that helps us realize our potential. It may be what leronlimab was developed for but given all the conditions this could positively impact and potentially prevent from occurring, why wouldn't you want to get the many additional positive impacts of leronlimab? Psoriasis, MS, Alzheimers, Cancer, post-viral, etc. Granted it needs to be proven before we can state these for certain, but it's not as though we are pulling these out of a hat...there are years of research to back these indications up.

I know we have heard testimonials from HIV patients in the past but I would love to hear their experience with other diseases while on 700mg of leronlimab. Do some of these other indications we are pursuing occur with less of a frequency? It would be really interesting to know.

We should hopefully find out more on lenacapavir next week as they are presenting their trial data at the AIDS Society Conference on HIV Science but I like our drug better due to the potential for positive effects it likely has. Leronlimab's stats with HIV are pretty impressive too so it will be interesting to compare when we have the data.